Additional information
Specialty | |
---|---|
Dosage | |
Form | |
Presentation | |
Primary packaging | |
Specification | |
DCI | |
Classement VEIC | |
Therapeutic class | |
Sub Class | |
Laboratory | |
CHART | |
The duration of the conversation | |
Generic / Princeps | |
AMM | |
Date AMM | |
Range |
Treatment of essential hypertension. DUOFOR PLUS is indicated for patients whose blood pressure is insufficiently controlled by dual therapy. DUOFOR PLUS is indicated as replacement therapy in patients already treated with the combination of valsartan, amlodipine, and hydrochlorothiazide as separate tablets at the same strengths.
Specialty | |
---|---|
Dosage | |
Form | |
Presentation | |
Primary packaging | |
Specification | |
DCI | |
Classement VEIC | |
Therapeutic class | |
Sub Class | |
Laboratory | |
CHART | |
The duration of the conversation | |
Generic / Princeps | |
AMM | |
Date AMM | |
Range |